retatrutide how to use vs Tirzepatide vs Semaglutide What to Know About Retatrutide

Where Retatrutide Stands in Clinical Development Retatrutide has not completed FDA review and holds no marketing authorization

Rosenstock J, Raccah D, Kornyi L, et al

Our approach is centered on supporting you with the highest standard of care every step of the way

The cardiovascular and renal benefits of GLP-1 drugs are real and now well documented in outcome trials, but the receptor biology behind them is more indirect than it first appears

Biotechnology giant Biogen $BIIB said on Wednesday that it is acquiring immune drug developer Human Immunology Biosciences (HI-Bio) to boost its late-stage pipeline and immunology portfolio